Phase I study of an AI-designed oral formulation sets a new standard in drug development NOTTINGHAM, England, May 28, 2026 /PRNewswire/ -- Quotient Sciences today announces the successful initiation of a clinical study evaluating a novel drug product developed using artificial...
Hence then, the article about quotient sciences advances ai designed drug product into clinical development was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Quotient Sciences Advances AI-Designed Drug Product into Clinical Development )
Also on site :
- The essentials in your ‘big shop’ set to cost even more thanks to the energy crisis
- Researchers let AI models run a simulated society. Claude was the safest—and Grok committed 180 crimes and went extinct within 4 days
- Walmart's ‘Cute’ $12 Swim Shorts Are Stretchy, ‘Flattering,’ and Available in 19 Colors Ahead of Summer